Abeona Therapeutics Inc.
Abeona Therapeutics Inc. (ABEO) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · ABEO · as of Jun 8, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
33
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Abeona Therapeutics Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
ABEO insider buying and selling by quarter
ABEO insider selling · ABEO insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · ABEO ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
ABEO executive sell shares · ABEO board member insider trading · ABEO insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| May 26, 2026 | Alvino Mark Director | Gift | 500 | — | Form 4 |
| May 22, 2026 | Alvino Mark Director | Sale | 6,500 | $35K | Form 4 |
| May 15, 2026 | Crombez Eric Director | Sale | 26,143 | $145K | Form 4 |
| May 11, 2026 | Vasanthavada Madhav Chief Commercial Officer | Sale | 5,548 | $33K | Form 4 |
| Apr 1, 2026 | Goldan Keith A. Director | Award | 32,751 | — | Form 4 |
| Mar 31, 2026 | Seshadri Vishwas CEO · Director | Sale | 29,985 | $131K | Form 4 |
| Mar 16, 2026 | Vazzano Joseph Walter CFO | Sale | 785 | $4K | Form 4 |
| Feb 2, 2026 | Silverstein Christine Berni Director | Sale | 20,070 | $102K | Form 4 |
| Feb 2, 2026 | Wuchterl Donald A. Director | Sale | 14,814 | $75K | Form 4 |
| Feb 2, 2026 | Crombez Eric Director | Sale | 16,284 | $83K | Form 4 |
| Feb 2, 2026 | Alland Leila Director | Sale | 18,065 | $92K | Form 4 |
| Feb 2, 2026 | Alvino Mark Director | Sale | 2,000 | $10K | Form 4 |
| Jan 26, 2026 | Wuchterl Donald A. Director | Award | 37,313 | — | Form 4 |
| Jan 26, 2026 | Zeiher Bernhardt G Director | Award | 37,313 | — | Form 4 |
| Jan 26, 2026 | Crombez Eric Director | Award | 37,313 | — | Form 4 |
| Jan 26, 2026 | Silverstein Christine Berni Director | Award | 37,313 | — | Form 4 |
| Jan 26, 2026 | Amoroso Michael Director | Award | 37,313 | — | Form 4 |
| Jan 26, 2026 | Charles Faith L. Director | Award | 37,313 | — | Form 4 |
| Jan 26, 2026 | Alvino Mark Director | Award | 37,313 | — | Form 4 |
| Jan 26, 2026 | Alland Leila Director | Award | 37,313 | — | Form 4 |
| Jan 20, 2026 | Vasanthavada Madhav Chief Commercial Officer | Award | 76,621 | — | Form 4 |
| Jan 22, 2026 | Vasanthavada Madhav Chief Commercial Officer | Sale | 12,610 | $67K | Form 4 |
| Jan 22, 2026 | Vazzano Joseph Walter CFO | Sale | 18,666 | $100K | Form 4 |
| Jan 22, 2026 | Seshadri Vishwas CEO · Director | Sale | 69,832 | $372K | Form 4 |
| Jan 22, 2026 | O'Malley Brendan M. SVP, Chief Legal Officer | Sale | 13,578 | $72K | Form 4 |
Vasanthavada Madhav
Chief Commercial Officer
Date
May 11
Shares
5,548
Price
$5.96
Value
$33K
Silverstein Christine Berni
Director
Date
Feb 2
Shares
20,070
Price
$5.09
Value
$102K
Vasanthavada Madhav
Chief Commercial Officer
Date
Jan 20
Shares
76,621
Price
—
Value
—
Vasanthavada Madhav
Chief Commercial Officer
Date
Jan 22
Shares
12,610
Price
$5.29
Value
$67K
O'Malley Brendan M.
SVP, Chief Legal Officer
Date
Jan 22
Shares
13,578
Price
$5.33
Value
$72K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About ABEO insider trading
ABEO insider trades
Abeona Therapeutics Inc. (ABEO) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Seshadri Vishwas (CEO · Director), Alvino Mark (Director), Vazzano Joseph Walter (CFO). Over the past 12 months, 5 insiders have filed transactions with the SEC. ABEO insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Abeona Therapeutics Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
ABEO insider trading · 5 questionsThe insiders of Abeona Therapeutics Inc. (ABEO) include executives and directors such as Seshadri Vishwas (CEO · Director), Alvino Mark (Director), Vazzano Joseph Walter (CFO), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026